Successful treatment of CD7-positive, undifferentiated acute leukemia with recombinant interferon alpha.
Sasaki
S
S
Fukawa
H
H
Motomura
S
S
Mohri
H
H
Ohkubo
T
T
Katayama
R
R
D000208:Acute Disease; D000227:Adenine Nucleotides / Q000378:metabolism; D000368:Aged; D015703:Antigens, CD / Q000032:analysis; D019011:Antigens, CD7; D000945:Antigens, Differentiation, T-Lymphocyte / Q000032:analysis; D002454:Cell Differentiation; D006801:Humans; D016130:Immunophenotyping; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D007938:Leukemia / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D008297:Male; D009843:Oligoribonucleotides / Q000378:metabolism; D011994:Recombinant Proteins
D000227:Adenine Nucleotides; D015703:Antigens, CD; D019011:Antigens, CD7; D000945:Antigens, Differentiation, T-Lymphocyte; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D009843:Oligoribonucleotides; D011994:Recombinant Proteins; C023505:2',5'-oligoadenylate